Archive for October, 2011
XToll Completely Prevented Cutaneous Lupus In Animal Study
CBio Limited have announced the publication of their animal trial on the advanced access site of the Oxford Journals publication, Nephrology Dialysis Transplantation. The research is titled – “Recombinant chaperonin10 (Xtoll) suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice.” According to results of the study, using XToll to treat mice completely prevented cutaneous lupus…
Original post by Wife of a Diabetic
No commentsProfessionals Aim To Transform Cancer Treatment In 10 Years
Leading investigators, scientists and clinicians from America and Europe met at Christ’s College, Cambridge in order to launch a novel initiative to revolutionize cancer treatment. Their aim is to transform the disease from terminal to manageable, chronic condition within the next decade…
Original post by Allergy News From Medical News Today
No commentsDementia Costs Europe 189 Billion Euros A Year
New research from Oxford University in England estimates the total cost of dementia across 15 western European countries in 2007 was €189 (£165) billion, most of which is made up of unpaid care from family and friends. The Alzheimer’s Research UK-funded study is currently in press and about to be published in the Journal of Alzheimer’s Disease…
Original post by Allergy News From Medical News Today
No commentsOvarian Cancer Spread Fuelled By Abdominal Fat Cells
Fat cells in the omentum, a large fatty pad of tissue that drapes over the intestines in the abdomen, fuel the spread of ovarian cancer by providing nutrients and energy for rapid tumor growth, according to a new study published online in Nature Medicine at the weekend…
Original post by Allergy News From Medical News Today
No commentsCranberry Juice Better Than Extracts At Fighting Bacterial Infections
With scientific evidence now supporting the age-old wisdom that cranberries, whether in sauce or as juice, prevent urinary tract infections, people have wondered if there was an element of the berry that, if extracted and condensed, perhaps in pill form, would be as effective as drinking the juice or eating cranberry sauce…
Original post by Wife of a Diabetic
No commentsSurprising New Findings Contradict Dominant Theory In Alzheimer’s Disease
For decades the amyloid hypothesis has dominated the research field in Alzheimer’s disease. The theory describes how an increase in secreted beta-amyloid peptides leads to the formation of plaques, toxic clusters of damaged proteins between cells, which eventually result in neurodegeneration. Scientists at Lund University, Sweden, have now presented a study that turns this premise on its head…
Original post by Allergy News From Medical News Today
No commentsThanksgiving Holiday Stuffed With Allergy, Asthma Triggers
Thanksgiving is about family, food and travel. And for the millions of Americans with allergies or asthma, it’s about navigating a minefield of triggers, from the pumpkin pie to the dusty guest bedroom. “A number of holiday-related triggers can make people sneeze, wheeze or, in the case of food allergies, have a more serious reaction,” said allergist Dr…
Original post by Allergy News From Medical News Today
No commentsSix Tips To Ensure Allergies And Asthma Don’t Ruin Holiday Cheer
Holiday gatherings are festive fun, but it’s not easy to be the life of the party when you’re sniffling, sneezing and wheezing. From the host’s overpowering perfume to the nuts in the snack bowl, holiday parties can be a challenge for people with allergies and asthma. “During the holiday season you’re going to be exposed to allergens,” said allergist Dr. Myron Zitt, M.D…
Original post by Allergy News From Medical News Today
No commentsConsortium Gets $7.2 M Contract Renewal To Promote Phase II Clinical Trials
The National Cancer Institute recently awarded $7.2 million for the competitive renewal of the Southeast Phase 2 Consortium (SEP2C), led by Moffitt Cancer Center’s Daniel Sullivan, M.D., executive vice president and associate center director for Clinical Investigations. The renewal is through September 2016…
Original post by Allergy News From Medical News Today
No commentsGlitazone Pretreatment Can Boost Efficacy Of Radioiodine Therapy In Metastatic Thyroid Cancer
Repeated radio-ablation therapy with iodine-131 to treat metastatic thyroid cancer can be less effective than the initial round of treatment due to de-differentiation of the cancer cells as the disease progresses, making them less sensitive to I-131. Glitazones, a class of PPARg drugs capable of re-differentiating the cancer cells, can enhance their I-131 uptake…
Original post by Allergy News From Medical News Today
No comments